Mulmit

Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.

VNDA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31216,105,000-151,168,000-220,500,000-3.74
2024-12-31198,772,000-40,660,000-18,900,000-0.33
2023-12-31192,640,000-13,952,0002,500,0000.04
2022-12-31254,382,0006,329,0006,300,0000.11
2021-12-31268,682,00042,165,00033,200,0000.58

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-04McGuire Daniel PatrickSVP, GC and Secretary80,000
2026-06-04Chrousos Phaedra41,600
2026-06-04Duncan Charles Cliff41,600
2026-06-04DUGAN RICHARD W41,600
2026-06-04Ward Anne Sempowski41,600
2026-06-04Honore Tage41,600
2026-06-04Mitchell Stephen Ray41,600
2026-05-18Mitchell Stephen Ray25,836
2026-04-22Duncan Charles Cliff57,101
2026-03-02Moran Kevin PatrickSVP, CFO & Treasurer42,442
2026-03-02Wijkstrom JoakimSVP, Chief Marketing Officer30,800
2026-03-02Williams TimothySVP & General Counsel42,434

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-06-05Submission of matters to a vote
2026-05-06Results of operations · Financial statements and exhibits
2026-04-22Officer or director change · Financial statements and exhibits
2026-04-02Officer or director change
2026-03-10Regulation FD disclosure
2026-02-23Other events · Financial statements and exhibits
2026-02-19Officer or director change · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.